Sinofn Health
Sinofn Health
In the current global economic landscape, the supplement industry is undergoing a seismic shift. Brands are no longer merely "private labeling"—they are engaged in Precision Nutrition Engineering. Consumers worldwide are demanding transparency, clinical validation, and personalized delivery formats. SINOFN Health stands at the intersection of this demand, providing a bridge between advanced molecular research and scalable manufacturing.
The market has moved past generic multivitamins. We are seeing a surge in demand for cognitive health (nootropics), metabolic support (PKU and specialized medical foods), and sustainable "clean label" formulations. For global enterprise buyers, the challenge is not just finding a supplier, but finding a partner capable of R&D-led innovation.
The concept of "Factory 4.0" is not a buzzword; it is the operational standard at SINOFN. By integrating IoT (Internet of Things), blockchain-based batch tracking, and AI-driven quality control, we ensure that every unit produced meets international GMP, ISO 22000, and HACCP standards. Our Supply Chain Resilience is built on redundant sourcing, ensuring that global partners never face stockouts, even in volatile trade climates.
One size does not fit all. Whether it’s formulating for European EFSA compliance, US FDA guidelines, or Southeast Asian flavor profiles, SINOFN utilizes its R&D centers in Tianjin and Shanghai to adapt formulations without compromising efficacy. We view our manufacturing as a localized extension of your brand.
SINOFN Health Co., Ltd. (est. 2025) operates as the dedicated manufacturing arm of the SINOFN Group. With origins dating back to 2012, we were founded on a mission to solve critical dietary needs, particularly in Phenylketonuria (PKU) management. Our expertise is rooted in scientific rigor, backed by the Chinese Academy of Sciences.
Founded by Mrs. GuoHong Liu, our journey began with a clinical imperative. Driven by the struggle of PKU families to access affordable specialized nutrition, Mrs. Liu founded SINOFN. Today, that legacy of "Profit with Purpose" defines our R&D culture, influencing how we approach every formula we manufacture for our global partners.
Our team is not just staff; it is an academic powerhouse. Led by Dr. Zhang Ying (Chinese Academy of Sciences) and Dr. Tan Shengjie (Peking University Medical), and reinforced by European expert Hans van Dijk, we optimize for bioavailability. We turn molecules into market-ready products.
We provide a full-spectrum OEM solution, from initial formulation and lab-scale prototyping to large-scale, automated production and global logistics compliance. We don't just supply; we co-create value.
We maintain pilot-scale production lines specifically for rapid iteration. Startups can test formulations in small batches before committing to full-scale commercial runs, minimizing market entry risk.
We operate under stringent international frameworks including ISO9001, ISO22000, HACCP, and HALAL. Our R&D center actively performs stability testing and dissolution validation to ensure shelf-life efficacy.
